Dewey Steadman
Stock Analyst at Canaccord Genuity
(0.69)
# 3,761
Out of 4,753 analysts
34
Total ratings
41.67%
Success rate
-25.59%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dewey Steadman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Maintains: Buy | $75 → $70 | $59.86 | +16.94% | 5 | Nov 12, 2018 | |
| PCRX Pacira BioSciences | Maintains: Hold | $45 → $49 | $26.84 | +82.56% | 14 | Oct 2, 2018 | |
| AMRX Amneal Pharmaceuticals | Maintains: Hold | $18 → $21 | $8.09 | +159.74% | 1 | Aug 14, 2018 | |
| ACET Adicet Bio | Downgrades: Sell | n/a | $0.89 | - | 4 | Apr 19, 2018 | |
| LPCN Lipocine | Downgrades: Hold | n/a | $4.45 | - | 3 | Jan 11, 2018 | |
| SVRA Savara | Maintains: Buy | $18 → $25 | $2.82 | +788.10% | 2 | Oct 30, 2017 | |
| PRGO Perrigo Company | Maintains: Buy | $88 → $100 | $25.14 | +297.85% | 5 | Sep 13, 2017 |
ANI Pharmaceuticals
Nov 12, 2018
Maintains: Buy
Price Target: $75 → $70
Current: $59.86
Upside: +16.94%
Pacira BioSciences
Oct 2, 2018
Maintains: Hold
Price Target: $45 → $49
Current: $26.84
Upside: +82.56%
Amneal Pharmaceuticals
Aug 14, 2018
Maintains: Hold
Price Target: $18 → $21
Current: $8.09
Upside: +159.74%
Adicet Bio
Apr 19, 2018
Downgrades: Sell
Price Target: n/a
Current: $0.89
Upside: -
Lipocine
Jan 11, 2018
Downgrades: Hold
Price Target: n/a
Current: $4.45
Upside: -
Savara
Oct 30, 2017
Maintains: Buy
Price Target: $18 → $25
Current: $2.82
Upside: +788.10%
Perrigo Company
Sep 13, 2017
Maintains: Buy
Price Target: $88 → $100
Current: $25.14
Upside: +297.85%